TEL AVIV (Reuters) – The chief executive of Teva Pharmaceutical Industries has stepped down, leaving new management to overhaul the world’s biggest maker of generic drugs and restore confidence after a series of missteps sent its shares plummeting.
Teva CEO exits amid crisis of confidence at drugmaker
Feb 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital